Lotus Pharmaceutical Co., Ltd. appointed Mr. Arni Hardarson as Representative of Institutional Director in place of Joel Morales, effective 1 January 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
281 TWD | -0.35% |
|
-8.32% | +3.31% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.31% | 2.29B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Change of the Representative of Institutional Director